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Abstract. 
 
The mechanisms underlying downregulation 
 
of the cadherin/catenin complexes and 
 
b
 
-catenin signal-
ing during tumor progression are not fully understood. 
We have analyzed the effect of oncogenic H-Ras on
E-cadherin/catenin complex formation/stabilization 
and 
 
b
 
-catenin distribution in epidermal keratinocytes. 
Microinjection or stable expression of V12Ras into ke-
ratinocytes promotes the loss of E-cadherin and 
 
a
 
-cate-
nin and relocalization of 
 
b
 
-catenin to the cytoplasm and 
nucleus. Moreover, these effects are dependent on 
PI3K (phosphoinositide 3-OH kinase) activity. Interest-
ingly, a strong association of p85
 
a
 
 and p110
 
a
 
 subunits 
of PI3K with 
 
b
 
-catenin is induced in V12Ras-expressing 
keratinocytes, and in vitro binding assays show a direct 
interaction between 
 
b
 
-catenin and p85
 
a
 
. Overexpres-
sion of either V12Ras or constitutively active p110
 
a
 
 in-
duces metabolic stabilization of 
 
b
 
-catenin and pro-
motes its accumulation in cytoplasmic and nuclear 
pools. In addition, the interaction of 
 
b
 
-catenin with the 
adenomatous polyposis coli protein is blocked in 
V12Ras and p110
 
a
 
 transformants though no changes in 
glycogen synthase kinase 3 
 
b
 
 activity could be detected. 
Nevertheless, in V12Ras transformants the in vivo 
phosphorylation of 
 
b
 
-catenin in Ser residues is strongly 
decreased. These results indicate that H-Ras activation 
induces the relocalization and cytoplasmic stabilization 
of 
 
b
 
-catenin by a mechanism involving its interaction 
with PI3K.
Key words: H-Ras • E-cadherin • 
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C
 
ELL
 
–cell adhesion mediated by the calcium-depen-
dent cadherin receptors is fundamental for the dif-
ferentiation and integrity of most adult tissues.
Among the different members of the cadherin superfam-
ily, the epithelial E-cadherin plays a pivotal role in the ac-
quisition and maintenance of embryonic and adult epi-
thelia (Takeichi, 1991; Gumbiner, 1996). E-cadherin is
organized in adhesion complexes at the lateral membranes
of neighboring cells. The receptor associates with cytoplas-
mic proteins of the catenin family, 
 
a
 
-, 
 
b
 
-, and 
 
g
 
-catenin
(identical to plakoglobin), which in turn mediate the inter-
action of the complexes with the cortical actin microfila-
ment network (Kemler, 1993; Aberle et al., 1996). 
 
b
 
-cate-
nin and plakoglobin directly bind the cytoplasmic domain
of E-cadherin, whereas 
 
a
 
-catenin interacts with the other
two catenins establishing the link with the actin microfila-
ments (Hinck et al., 1994; Nagafuchi et al., 1994; Jou et al.,
1995; Knudsen et al., 1995; Rimm et al., 1995). An addi-
tional catenin, p120cas, has been described in some E-cad-
herin/catenin complexes but apparently with a weak inter-
action with 
 
a
 
-catenin (Reynolds et al., 1994; Daniel and
Reynolds, 1995).
Recent studies have clearly established that 
 
b
 
-catenin
has an important signaling activity besides its role in the
cadherin-mediated adhesion complexes. 
 
b
 
-catenin is ho-
mologous to the armadillo protein of 
 
Drosophila
 
, and to-
gether with other members constitute the 
 
arm
 
 protein
family (Peifer et al., 1992, 1994). Armadillo/
 
b
 
-catenin are
downstream effectors of the Wingless/Wnt signaling path-
way (for review see Gumbiner, 1995; Miller and Moon,
1996; Willert and Nusse, 1998). Their activity is mediated
by the pool of soluble molecules and appears to be inde-
pendent of their role in adhesive complexes (Orsulic and
Peifer, 1996).
In normal resting cells, the cytoplasmic 
 
b
 
-catenin levels
are very low and are regulated by interaction with the ade-
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nomatous polyposis coli (APC)
 
1 
 
product and by the up-
stream effectors of the Wnt signaling pathway, glycogen
synthetase kinase 3
 
b 
 
(GSK3
 
b
 
) and axin (Munemitsu et al.,
1995; Rubinfeld et al., 1996; Yost et al., 1996; Ikeda et al.,
1998; Sakanaka et al., 1998). These proteins probably di-
rect the proteolytic degradation of 
 
b
 
-catenin by the ubiq-
uitin-proteasome pathway (Aberle et al., 1997; Orford et
al., 1997). Wnt signaling inhibits the activity of GSK3
 
b
 
(Cook et al., 1996) and leads to the stabilization of cyto-
plasmic hypophosphorylated 
 
b
 
-catenin, which is able to in-
teract with lymphocyte enhancer factor 1/T-cell factor
(Lef-1/Tcf) transcription factors and the complex can act
as a transcriptional coactivator in the nucleus (Behrens et
al., 1996; Huber et al., 1996; Molenaar et al., 1996; Papkoff
et al., 1996). Other studies have also reported that 
 
b
 
-cate-
nin can be translocated to the nucleus independent of its
interaction with Lef-1/Tcf transcription factors (Fagotto et
al., 1998; Prieve and Waterman, 1999).
It has been recently shown that activation of 
 
b
 
-catenin
signaling occurs in intestinal and mammary cells after acti-
vation of the integrin-linked kinase, independent of Wnt
activation but also involving downregulation of GSK3
 
b
 
activity (Novak et al., 1998; Delcommenne et al., 1998).
Significantly, the interaction of 
 
b
 
-catenin and APC is dis-
turbed in colon carcinoma and melanoma cell lines with
mutations in the interacting regions of either molecule
(Korinek et al., 1997; Morin et al., 1997; Rubinfeld et al.,
1997). Mutations in the serine/threonine residues suscepti-
ble of phosphorylation and interaction with APC in the
 
b
 
-catenin gene have also been found in a variety of human
carcinomas (Miyoshi et al., 1998; Palacios and Gamallo,
1998; Voeller et al., 1998), in some cases associated with
extensive nuclear localization of 
 
b
 
-catenin (Palacios and
Gamallo, 1998). These observations have fostered an in-
creasing interest in the role of 
 
b
 
-catenin in tumor progres-
sion regarding the possibility of its functioning as an onco-
gene (Peifer, 1997).
Oncogenic transformation frequently results in alter-
ations of the epithelial properties, including loss of po-
larized morphology, less organized cell junctions, and
increased migration of transformed epithelial cells (Vlem-
inckx et al., 1991; Behrens et al., 1993; Kinch et al., 1995;
Zhong et al., 1997). In some reports, changes in the E-cad-
herin/catenin complexes were associated to a decreased
interaction of the complexes with the cytoskeleton and an
increase in tyrosine phosphorylation of 
 
b
 
-catenin and/or
association with p120cas (Behrens et al., 1993; Kinch et al.,
1995).
Recently, Ras activation has been shown to induce
the destabilization of E-cadherin/catenin complexes in
MDCK cells by mechanisms involving both phospho-
inositide 3-OH kinase (PI3K) and mitogen-activated pro-
tein kinase (MAPK) effector pathways (Potempa and Rid-
ley, 1998). Ras activation is a frequent genetic alteration in
human and experimental tumors (Barbacid, 1987), but it is
presently unknown whether it is involved in 
 
b
 
-catenin sig-
naling during tumor progression. The experimental model
of mouse skin carcinogenesis offers a unique system to in-
vestigate this important issue as Harvey-Ras (H-Ras) acti-
vation is a frequent genetic event at the initiation stage
(Brown et al., 1986; Quintanilla et al., 1986). Further alter-
ations in the 
 
ras
 
 locus, leading to an increase in the dosage
of activated H-Ras, accumulate during progression of pap-
illomas to invasive carcinomas (Bianchi et al., 1990; Brem-
ner and Balmain, 1990). Downregulation of E-cadherin
expression also occurs at this stage during mouse skin tu-
mor progression (Navarro et al., 1991) and alterations in
the integrity of the E-cadherin–mediated cell–cell adhe-
sion have been found in high risk progressing papillomas
(Cano et al., 1996).
To get further insights into the role of Ras activation in
tumor development, we have investigated the effects of ac-
tivated H-Ras on the organization of E-cadherin/catenin
complexes and on 
 
b
 
-catenin localization in mouse epider-
mal keratinocytes. Here we show that activated H-Ras al-
ters the distribution of 
 
b
 
-catenin in epidermal kerati-
nocytes in the membrane-bound and cytoplasmic/nuclear
pools in a PI3K-dependent manner. Our results indicate
that Ras signaling interferes with the 
 
b
 
-catenin–APC in-
teraction and promotes the interaction of soluble 
 
b
 
-cate-
nin with PI3K and the metabolic stabilization of cytoplas-
mic 
 
b
 
-catenin pools.
 
Materials and Methods
 
Cells and Retroviral Infections
 
Mouse Pam212 keratinocytes, an immortalized cell line spontaneously de-
rived from a primary keratinocyte culture (Yuspa et al., 1980) and GP
 
1
 
E
86 cells producing retroviruses that express either V12H-Ras or the cata-
lytic subunit of PI3K targeted to the plasma membrane (p110CAAX)
were grown in DME supplemented with 10% FCS (GIBCO BRL), 100
 
m
 
g/ml ampicillin, 32 
 
m
 
g/ml gentamicin, and 100 
 
m
 
g/ml amphotericin B
(Sigma Chemical Co.). Cells were grown at 37
 
8
 
C in a humidified 5% CO
 
2
 
atmosphere. Retroviruses encoding V12H-Ras with a neomycin resistance
marker or controls with the neomycin resistance marker alone have been
previously described (Rodríguez-Viciana et al., 1997). Retrovirus encod-
ing p110CAAX was generated by subcloning the BamHI insert from
pSG5-p110CAAX into pLXSP3. pLXSP3 was a gift from A. Sewing (Im-
perial Cancer Research Fund, London, UK) and was generated by ligating
the HindIII-XbaI fragment of pBabe puro, containing the puromycin re-
sistance gene, into pLXSN. Infective retroviruses were obtained by grow-
ing GP
 
1
 
E 86 cells to confluence and collecting the culture medium. Su-
pernatants were filtered through 0.45-mm pores and frozen as aliquots in
the presence of polybrene. Retrovirus-containing supernatants were
added to subconfluent cultures of Pam212 cells and replaced 16 h later
with fresh medium. Pools of infected cells were obtained after selection
with 400 
 
m
 
g/ml G418 (Calbiochem-Novabiochem Co.) or 1.5 
 
m
 
g/ml puro-
mycin (Boehringer Mannheim) for 7 d, during which time all control non-
infected cells died. More than 200 colonies were pooled from each infec-
tion.
 
Antibodies
 
The following antibodies were used: rat monoclonal anti-mouse E-cad-
herin (ECCD-2; a gift from Dr. M. Takeichi, Kyoto University, Kyoto, Ja-
pan); mouse monoclonal anti–
 
b
 
-catenin, mouse monoclonal anti–
 
a
 
-cate-
nin, mouse monoclonal anti-GSK3
 
b
 
, and mouse antiphosphotyrosine
(PY20) (Transduction Laboratories); mouse monoclonal anti–c-H-Ras
(Ab-1) and mouse monoclonal anti-pan Ras recognizing the normal and
activated forms of H-Ras (Oncogene Science, Inc.); mouse monoclonal
anti–6-His (CLONTECH Laboratories); rabbit anti–GSK3
 
b
 
-P-Ser
 
9
 
 anti-
serum (Chemicon International Inc.; provided by Dr. F. Wandosell, Cen-
tro de Biología Molecular, Madrid, Spain); rabbit polyclonal anti-GST
(Sigma Chemical Co.); rabbit antipeptide antiserum anti–
 
a
 
-catenin (VB1)
 
1. 
 
Abbreviations used in this paper: 
 
APC, adenomatous polyposis coli;
GST, glutathione-S-transferase; GSK3
 
b
 
, glycogen synthase kinase 3
 
b
 
;
H-Ras, Harvey-Ras; Lef-1/Tcf, lymphocyte enhancer factor 1/T cell fac-
tor; MAPK, mitogen-activated protein kinase; PI3K, phosphoinositide
3-OH kinase; PP2A, protein phosphatase 2A. 
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and rabbit antipeptide antiserum anti–
 
b
 
-catenin (VB2) (Braga et al.,
1995); rabbit polyclonal anti-APC (N-15) (Santa Cruz Biotechnology,
Inc.); rabbit polyclonal anti–PI3 kinase p85 and anti–PI3 kinase p110
 
a
 
(Upstate Biotechnology); and mouse monoclonal anti–
 
b
 
-tubulin (Amer-
sham). Secondary antibodies included: BODIPY-conjugated goat anti–rat
IgG, anti–mouse IgG and anti–rabbit IgG (Molecular Probes Inc.);
AMCA-conjugated rabbit anti–rat IgG, Cy5-conjugated donkey anti–rab-
bit IgG (Jackson ImmunoResearch Laboratories) and peroxidase-conju-
gated sheep anti–rat IgG, anti–mouse IgG and anti–rabbit IgG (Amer-
sham).
 
Recombinant Proteins and Microinjection
 
Recombinant constitutively active Ras (V12Ras), dominant negative Ras
(N17Ras), C3 transferase and dominant negative Rac (N17Rac) were pre-
pared as glutathione-S-transferase (GST) fusion proteins in 
 
Escherichia
coli
 
, purified using glutathione-Sepharose beads, thrombin cleaved, dia-
lyzed, and concentrated as described (Ridley et al., 1992). The activity of
each batch of recombinant proteins was tested in fibroblasts and kerati-
nocytes as described (Braga et al., 1997). Recombinant GST–
 
b
 
-catenin fu-
sion protein was generated by isolation of full-length human 
 
b
 
-catenin
cDNA from plasmid pQE32 (a gift of Dr. J. Behrens) by SmaI-SalI diges-
tion and ligation into pGEX-5X-2 plasmid (Pharmacia Biotech). Recom-
binant His-p85
 
a
 
 wt fusion protein was produced in COS cells as described
(Rodríguez-Viciana et al., 1997) and purified with His-Trap columns
(Pharmacia Biotech) following the instructions of the manufacturer. Con-
fluent patches of keratinocytes were injected essentially as described
(Braga et al., 1997) and visualized by mixing the recombinant proteins
with dextran conjugated to Texas red (mol wt 10,000; Sigma Chem-
ical Co.).
 
Immunostaining
 
After microinjection, cells were fixed in either cold methanol or 3.7%
buffered formaldehyde for 5 min at 4
 
8
 
C and rinsed in PBS. Staining with
the different antibodies was performed as described (Lozano and Cano,
1998). In extraction experiments, cells grown on coverslips were treated
with NT buffer (50 mM Tris, pH 7.4, 100 mM NaCl, 5 mM MgCl
 
2
 
, 5 mM
Ca
 
2
 
Cl, 1% NP-40, 1% Triton X-100) for 15 min on ice before fixation and
staining. Preparations were viewed either by confocal microscopy or in an
Axiophot photomicroscope (Carl Zeiss). Confocal images were obtained
using a laser scanner (MRC 1024; BioRad) attached to a Nikon micro-
scope (Optiphot 2). Pictures were processed using the Adobe Photoshop
4.0 software (Adobe Systems, Inc.).
 
Preparation of Cell Extracts
 
Whole cell extracts were obtained from F-25 flasks of 80–90% confluent
cells. For total protein extracts, cells were washed twice in cold HMF-Ca
buffer (10 mM Hepes, pH 7.4, 100 mM NaCl, 10 mM Ca
 
2
 
Cl) and extracted
in 1 ml of S buffer (50 mM Tris, pH 7.4, 100 mM NaCl, 5 mM MgCl
 
2
 
, 5
mM Ca
 
2
 
Cl, 2% SDS) containing protease and phosphatase inhibitors (2
mM PMSF, 20 
 
m
 
g/ml aprotinin, 1 mM 
 
N
 
-ethylmaleimide, 1 mM sodium
orthovanadate, 2 mM hydrogen peroxide) for 5 min at room temperature
under continuous agitation. Soluble and insoluble fractions were obtained
as previously described (Lozano and Cano, 1998) using the NT buffer con-
taining the inhibitors described above.
 
Immunoprecipitation and Western Blotting
 
Immunoprecipitations of soluble fractions were carried out with different
antibodies as previously described (Lozano and Cano, 1998) and analyzed
in 7.5% or 12% SDS-PAGE gels. In P-Tyr immunoprecipitations, con-
trols were performed by adding 5 mM P-Tyr or P-Ser (Sigma Chemical
Co.) to soluble fractions. Immunoblotting of the different fractions and im-
munoprecipitates was performed by transferring the gels to Immobilon
 
 
 
P
membranes (Millipore Corp.), incubation with the appropriate antibodies,
and development with an enhanced chemiluminescent kit (Amersham).
 
Pulse–Chase Analysis of 
 
b
 
-Catenin
 
Cells were grown in F-25 flasks to 80% confluence in normal growth me-
dium, washed three times in HMF-Ca buffer, and pulse-labeled for 1 h in 1
ml of methionine- and glutamine-free minimal essential medium (GIBCO
BRL) supplemented with 4 mM glutamine, 10% FCS and 100 
 
m
 
Ci
[
 
35
 
S]methionine-cysteine (trans-label; Amersham; 1,000 Ci/mmol). La-
beled cells were rinsed three times in normal growth medium containing
an excess of cold methionine (0.15 mg/ml), chased in this medium for the
indicated times, and the soluble extracts subjected to 
 
b
 
-catenin immuno-
precipitation. The labeled immunoprecipitates were resolved in 7.5%
SDS-PAGE gels, transferred to Immobilon
 
 
 
P
 
 
 
membranes, and exposed to
autoradiography. Bands corresponding to 
 
b
 
-catenin were identified by im-
munoblotting. 
 
35
 
S-labeled 
 
b
 
-catenin detected at the different experimental
points was quantified by scanning and digitalization of the autoradiograms
with Adobe Photoshop 4.0 and integration with NIH Image 1.62f soft-
ware. The integrated density obtained at the different times was normal-
ized to that obtained at time 0 h in each experiment.
 
In Vivo Phosphorylation and Phosphoamino Acid 
Analysis of 
 
b
 
-Catenin
 
Metabolic labeling of keratinocytes with [
 
32
 
P]orthophosphate was per-
formed as previously described (Pérez-Moreno et al., 1998) with slight
modifications. 20 h after plating the cells, monolayers were labeled in me-
dia without phosphate supplemented with 500 
 
m
 
Ci/ml of [
 
32
 
P]orthophos-
phate (acid-free, 5 
 
m
 
Ci/ml; Du Pont Company; NEN Life Science Prod-
ucts) for 4 h at 37
 
8
 
C in a CO
 
2
 
 incubator. After labeling, cells were washed
twice with PBS and lysed with NT buffer, containing a cocktail of phos-
phatase (1 mM sodium orthovanadate, 50 mM sodium fluoride, and 2 mM
hydrogen peroxide) and protease inhibitors for 30 min at 4
 
8
 
C with gentle
rotation. Extracts were prepared as described, immunoprecipitated with
anti–
 
b
 
-catenin antibodies (Transduction Laboratories), and resolved on
7.5% SDS-PAGE gels. Protease and phosphatase inhibitors were main-
tained during all the immunoprecipitation procedures. Total [
 
32
 
P]phos-
phate labeling was detected by autoradiography, and the total 
 
b
 
-catenin
protein was determined in the same gel by immunoblotting. 
 
32
 
P-labeled
and total 
 
b
 
-catenin were quantified by scanning and digitalization of the
autoradiograms and blots as described.
Phosphoamino acids were analyzed based on the method of Boyle et al.
(1991) with minor modifications. 
 
32
 
P-labeled phosphorylated 
 
b
 
-catenin
bands were excised from membranes and hydrolyzed with 6 N HCl at
110
 
8
 
C for 2 h. The hydrolysates were lyophilized using a speed-vac con-
centrator and resuspended in 10 
 
m
 
l of pH 1.9 buffer (2.2% formic acid,
7.8% acetic acid, pH 1.9) containing 2 
 
m
 
g each of cold phosphoamino acid
standards. The samples were spotted onto thin-layer cellulose plates
(5716; Merck) and amino acid separation was performed on an apparatus
(HTLE-7000; CBS Scientific Co.) running at 1,500 V for 45 min in the first
dimension with the pH 1.9 buffer. The second dimension thin layer chro-
matography was carried out in a mixture of n-buthanol/acetic acid/H2O
(100:22:50). The individual amino acids were identified by comparison
with the internal standards detected by ninhydrin staining. The position of
32P-labeled phosphoamino acids were determined by autoradiography.
GSK3b Activity
Activity of GSK3b was tested in the absence and presence of 50 mM lith-
ium chloride in crude cell extracts prepared following the procedure re-
cently described (Ryves et al., 1998) and using the specific phospho-
peptide GSM (RRRPASVPPSPSLSRHSSHQRR, where S indicates a
phosphoserine introduced during synthesis) (a gift of Dr. A.J. Harwood,
MRC Laboratory for Molecular Cell Biology, London, UK). The differ-
ence between the activity obtained in the absence and presence of lithium
chloride was represented as the specific GSK3b activity.
Pull-down and In Vitro Protein Binding Assays
Pull-down assays were performed using soluble extracts obtained in NT
buffer after preclearing with glutathione-Sepharose 4B (Pharmacia Bio-
tech). 200 ml of the precleared extracts were incubated with 100 ml of puri-
fied GST–b-catenin fusion protein (0.2 mg/ml) for 2 h at 48C. For in vitro
protein binding assays, 200 ng of both GST–b-catenin and His-p85a wt
were mixed in 500 ml of immunoprecipitation buffer and incubated 1 h at
48C. In all cases, interacting b-catenin–GST complexes were collected by
addition of glutathione-Sepharose 4B, washed twice with immunoprecipi-
tation buffer, and finally resuspended in Laemmli sample buffer. Com-
plexes were analyzed in 7.5% SDS-PAGE gels and immunoblotted with
the indicated antibodies.
Reporter Gene Assay
Nearly subconfluent cells were transfected in duplicate in P-60 dishes with
4 mg of the pRSV-LacZ containing a b-galactosidase reporter gene and 4The Journal of Cell Biology, Volume 146, 1999 970
mg of either pTOPFLASH or pFOPFLASH containing multimerized
wild-type or mutated Lef-1/Tcf binding sites, respectively, and a luciferase
reporter gene (Korinek et al., 1997) (a gift of Dr. H. Clevers, University
Hospital, Utrecht, The Netherlands). Transfection was performed with li-
pofectamine plus (GIBCO BRL). Luciferase and b-galactosidase activi-
ties were measured 24 h after transfection.
Results
Microinjection of Keratinocytes with Dominant Active 
H-Ras Induces Loss of E-Cadherin and a-Catenin and 
Relocalization of b-Catenin to the Cytoplasm
To analyze short-term effects of activated H-Ras on the
E-cadherin/catenin complexes, we chose the murine epi-
dermal keratinocyte cell line Pam212, obtained after spon-
taneous immortalization of a primary keratinocyte cell
culture (Yuspa et al., 1980). This cell line maintains all the
epidermal characteristics of keratinocytes, expresses a nor-
mal H-Ras protooncogene, and is nontumorigenic when
injected into athymic nude mice (Missero et al., 1991;
Sánchez-Prieto et al., 1995). The dominant active form of
H-Ras (V12Ras; 0.5 mg/ml) protein was microinjected in
confluent Pam212 keratinocytes showing stable cell–cell
contacts, and the cells were fixed and stained for different
proteins after 1–24 h of incubation. As shown in Fig. 1, 2–4 h
after microinjection E-cadherin (Fig. 1 b) and a-catenin
Figure 1. Microinjection of V12Ras in Pam212
keratinocytes induces dismantling of E-cadherin/
catenin complexes and the cytoplasmic relocal-
ization of b-catenin. Confluent patches of
Pam212 cells were microinjected with V12Ras
(0.5 mg/ml) (a–h) or N17Ras (0.5 mg/ml) (i–k),
and after 2–4 h fixed in 3.7% formaldehyde. Cells
were stained for E-cadherin (b and j), a-catenin
(d), and b-catenin (f, h, and k). Microinjected
cells were identified by coinjection of dextran–
Texas red (a, c, e, g, and i). Cells in c–f were fixed
after 2 h of microinjection and the rest of cells af-
ter 4 h of microinjection. V12Ras microinjection
induces a strong cytoplasmic staining and occa-
sional nuclear localization of b-catenin, whereas
E-cadherin and a-catenin disappear from cell–
cell contacts on microinjected and adjacent cells.
Images in a–h were obtained by confocal laser
microscopy and those in i–k in an Axiophot mi-
croscope. Bars, 10 mm.Espada et al. H-Ras Stabilization of b-Catenin 971
(Fig. 1 d) were completely absent from the cell–cell con-
tacts established between microinjected cells. At the same
time, V12Ras induced a strong cytoplasmic staining of en-
dogenous b-catenin (Fig. 1, f and h). In addition, a diffuse
nuclear labeling for b-catenin could be detected in some
of the microinjected cells (Fig. 1 h). Microinjection of
Pam212 cells with a dominant negative H-Ras protein,
N17Ras induced no alterations in the adhesion complexes
or b-catenin localization (Fig. 1, j and k). Our data indicate
the specificity of V12Ras effects and are in agreement with
previous data using anti–Ras antibodies in human kerati-
nocytes (Braga, V.M.M., M. Betson, and N. Lamarche-Vane,
manuscript submitted for publication). 16 h after V12Ras
microinjection in Pam212 cells, E-cadherin and a-catenin
remained absent from the cell–cell contacts and b-catenin
was still faintly detected in the cytoplasm (data not shown),
indicating that dominant active H-Ras induces dismantling
of E-cadherin/catenin complexes and cytoplasmic accumu-
lation of b-catenin in mouse epidermal keratinocytes.
The possible participation of Rho and Rac in the dis-
sociation of E-cadherin complexes induced by V12Ras
in confluent mouse keratinocytes was also investigated.
However, inhibition of endogenous Rho or Rac affected
primarily the adhesion to substratum, resulting in the de-
tachment of the cells from the dish within 2 h without af-
fecting cell–cell contacts (data not shown), in contrast to
our previous studies in human keratinocytes (Braga et al.,
1997). These results might reflect a modulation on the re-
sponse of cadherin receptors to inhibition of small GTP-
ases because of the cellular context (Braga et al., 1999)
and/or to specific effects of the extracellular matrix (San-
der et al., 1998).
Destabilization of E-Cadherin/Catenin Complexes 
Induced by V12Ras Depends on PI3K and Is 
Independent of b-Catenin Tyrosine Phosphorylation
Previous studies have implicated PI3K and MAPK activi-
ties in dismantling E-cadherin/catenin complexes induced
by activated V12Ras in other systems (Potempa and Rid-
ley, 1998; Sander et al., 1998). In murine keratinocytes, the
involvement of PI3K in the destabilization of E-cadherin/
catenin complexes induced by activated H-Ras was con-
firmed by microinjection analysis in the presence of spe-
cific inhibitors. Preincubation of Pam212 cells during 30
min with the PI3K inhibitor wortmannin at 200 nM,
blocked the effect of V12Ras on the adherens junctions
(Fig. 2 a).
To further investigate the effect of activated Ras and the
involvement of PI3K in the destabilization of the E-cad-
herin/catenin complexes, we generated stable transfec-
tants of Pam212 cells expressing H-V12Ras by retroviral
transduction. Cells were pooled from three independent
infection assays, which showed similar results. The solubil-
ity of E-cadherin/catenin complexes in control PamNeo
(Neo)- and V12Ras-overexpressing (Ras) cells was first
analyzed by immunostaining after detergent extraction of
the cells. As showed in Fig. 2 b, E-cadherin and b-catenin
were preserved at cell–cell contacts of control Neo cells af-
ter treatment with NT buffer (Fig. 2 b, Neo). Both proteins
were removed from cell–cell contacts by the detergent
treatment in Ras cells (Fig. 2 b, Ras), indicating that
H-Ras activation promotes solubilization of the cadherin
complexes. This solubilization was prevented by preincu-
bation of Ras cells with wortmannin during 1 h (Fig. 2 b,
Ras1W), further supporting the involvement of PI3K ac-
tivity in H-Ras–induced destabilization of the adhesion
complexes.
Immunoblotting analysis of the distribution of the dif-
ferent components of the E-cadherin/catenin complexes
into the detergent-soluble (S) and insoluble (I) fractions of
control neomycin (Neo)- and V12Ras (Ras)-transduced
cells is shown in Fig. 3 a. E-cadherin and b-catenin were
found in both the soluble and insoluble fractions in Neo
cells, whereas in Ras-expressing cells, most of the E-cad-
herin and b-catenin and an increased proportion of a-cate-
nin were detected in the soluble fraction. Quantification of
the data obtained in three independent experiments indi-
cated that 8% and 11% of E-cadherin and b-catenin, re-
spectively, were detected in the insoluble fractions of Ras
cells. In contrast, in control Neo cells, 39% of E-cadherin
and 29% of b-catenin were associated to the insoluble
fraction. In addition, the distribution in soluble and insolu-
ble fractions of a control protein, b-tubulin, was not dis-
turbed upon V12Ras overexpression (Fig. 3 a). These
results confirm that the components of the E-cadherin
complexes were weakly associated to the actin cytoskele-
ton in the Ras-expressing cells.
Immunoblot analysis of total protein extracts of Neo
and Ras cells showed that the level of p21 protein in-
creased about 10-fold in PamV12Ras cells (Fig. 3 b). Total
protein levels of E-cadherin and a-catenin decreased in
V12Ras-overexpressing cells (Ras) as compared with con-
trol cells (Neo), but no changes in b-catenin levels were
observed (Fig. 3 b). On the other hand, soluble E-cadherin
of either Neo and Ras keratinocytes was able to associate
in a similar manner to the a- and b-catenin components
(Fig. 3 c, left). Immunoprecipitation of tyrosine-phosphor-
ylated proteins in the soluble fraction of Pam212 kerati-
nocytes showed a similar degree of b-catenin tyrosine
phosphorylation in both Neo and Ras cells (Fig. 3 c, right)
and the absence of tyrosine phosphorylation in E-cadherin
and  a-catenin in both cell lines. These results indicated
that stable expression of dominant active H-Ras decreases
the total levels of E-cadherin and a-catenin without affect-
ing the level of b-catenin and, more significantly, induces
the redistribution of the different components to a more
soluble cytoplasmic pool.
Interaction of b-Catenin with PI3K Is Strongly Induced 
in Ras-transformed Keratinocytes
To get further insights into the H-Ras–induced cytoplas-
mic relocalization of b-catenin, we analyzed the participa-
tion of PI3K. Cell extracts obtained from control (Neo)
and PamV12Ras (Ras)-transduced cells were immuno-
precipitated with antibodies against the regulatory subunit
of PI3K (p85a), and the presence of b-catenin was ana-
lyzed by immunoblotting. As shown in Fig. 4 a, b-catenin
was detected in the p85a immunocomplexes from control
Neo cells, but a significant increase of associated b-catenin
was detected in the immunocomplexes of Ras cells. How-
ever, the level of total (data not shown) and immunopre-
cipitated p85a (Fig. 4 a) was similar in both cell types. TheThe Journal of Cell Biology, Volume 146, 1999 972
reverse experiment, immunoprecipitation with anti–b-cat-
enin antibodies and immunoblotting with anti-p85a (Fig. 4
a), also showed an increase in b-catenin/p85a association
in Ras cells. In addition, the strong association of b-cate-
nin with the PI3K complex in Ras cells was also detected
when the p110a catalytic subunit was immunoprecipitated
(Fig. 4 a). Interestingly, the interaction of p110a with its
regulatory subunit, p85a, was also significantly increased
in Ras cells.
The interaction of b-catenin with PI3K was confirmed in
pull-down experiments with recombinant GST–b-catenin.
As shown in Fig. 4 b, an excess of recombinant GST–
b-catenin interacts similarly with endogenous p85a de-
rived from protein extracts of Neo and Ras cells. These re-
sults suggest that endogenous p85a, from either control or
V12Ras cells has the same ability to associate with recom-
binant b-catenin. The quantitative differences found in the
in vivo b-catenin–p85a interaction might reflect different
properties of endogenous b-catenin in control and Ras-
expressing cells. GST–b-catenin recombinant protein also
showed a strong interaction with E-cadherin and a-catenin
in the pull-down assays (Fig. 4 b, and data not shown), in-
Figure 2. Inhibition of PI3K activity prevents
E-cadherin/catenin complexes disassembly in-
duced by V12Ras. (a) Confluent patches of
Pam212 cells were preincubated with the PI3K
inhibitor wortmannin (200 nM) for 30 min, mi-
croinjected with V12Ras (0.5 mg/ml), and after
3 h, fixed in methanol. Cells were stained for
E-cadherin, and microinjected cells were identi-
fied by coinjection of dextran–Texas red. (b)
Control PamNeo (top, Neo) or PamV12Ras
(middle and bottom, Ras) cells were extracted in
NT buffer for 15 min on ice, fixed in 3.7% for-
maldehyde, and stained for E-cadherin (left) or
b-catenin, using mouse mAb (right). PamV12Ras
cells showed in the bottom were preincubated
with the PI3K inhibitor wortmannin (Ras1W)
for 1 h before NT buffer extraction. The nuclear
staining detected with b-catenin is background
staining because of nonspecific binding of the
BODIPY-conjugated anti–mouse IgG observed
after detergent extraction. Both E-cadherin and
b-catenin are redistributed to the detergent solu-
ble fraction in V12Ras-expressing cells and this
solubilization is blocked after inhibition of PI3K
activity in those cells. Images were obtained in an
Axiophot microscope. Bars, 10 mm.Espada et al. H-Ras Stabilization of b-Catenin 973
dicating the functionality of the protein in in vitro interac-
tions. A direct interaction of b-catenin with the regulatory
subunit of PI3K, p85a, was further demonstrated in in
vitro binding assays using recombinant GST–b-catenin
and His-p85a wt fusion proteins (Fig. 4 c). Taken together,
these results indicate the ability of b-catenin to associate
with PI3K in Pam212 keratinocytes. This interaction is sig-
nificantly increased in V12Ras-overexpressing cells, where
Figure 3. Biochemical analysis of the components and distribution
of E-cadherin/catenin complexes in control Neo and Ras kerati-
nocytes. (a) Soluble (S) and insoluble (I) fractions obtained in NT
buffer from PamNeomycin (Neo)- and PamV12Ras (Ras)-trans-
duced cells were immunoblotted for E-cadherin, a-catenin (mouse
monoclonal), b-catenin (mouse monoclonal), and b-tubulin. (b) To-
tal cell extracts obtained in S buffer from PamNeomycin (Neo) and
PamV12Ras (Ras) cells were immunoblotted for E-cadherin, a-cate-
nin, b-catenin, b-tubulin, and p21ras. (c) Soluble extracts obtained in
NT buffer from PamNeomycin (Neo) and PamV12Ras (Ras) cells
were immunoprecipitated with anti–E-cadherin antibodies (ECCD-2)
(left) or with antiphosphotyrosine antibodies (PY20) (right) and sub-
jected to immunoblotting for E-cadherin, a-catenin, and b-catenin.
Bands detected in the P-Tyr immunocomplexes were specifically
competed by an excess of P-Tyr but not by P-Ser.
Figure 4. Interaction of phospho-
inositide 3-OH kinase with b-cate-
nin in vivo and in vitro. (a) In vivo
interactions. Soluble extracts
from  PamNeomycin (Neo) and
PamV12Ras (Ras) cells were immu-
noprecipitated with anti-p85a se-
rum (top), anti-p110a serum (mid-
dle), or anti–b-catenin antibody
(mouse monoclonal) (bottom) and
subjected to immunoblotting for
b-catenin and p85a as indicated. (b)
Pull-down assays. Recombinant
GST–b-catenin fusion protein (200
ng) was incubated with soluble ex-
tracts from PamNeomycin (Neo)
and PamV12Ras (Ras) cells, and
the complexes were immunoblot-
ted for E-cadherin (top) and p85a
(middle). As an internal control the
complexes were also immunoblot-
ted for b-catenin (bottom). (c) In
vitro interaction of b-catenin and
p85a. 200 ng of recombinant His-
p85a wt fusion protein was incu-
bated in the presence or absence of
200 ng of recombinant GST–b-catenin fusion protein in immunoprecipitation buffer. Complexes were affinity-purified with glu-
tathione-4B-Sepharose beads (AP:GST) (middle and right lanes) and detection of b-catenin and p85a wt was performed by immuno-
blotting with anti-GST (GST) (top) and anti–6-His (His) antibodies (bottom), respectively. As an internal control, the presence of His-
p85a wt in the precipitation buffer was tested before the addition of GST–b-catenin (left lanes).The Journal of Cell Biology, Volume 146, 1999 974
both the regulatory and catalytic subunits of PI3K form
part of this novel b-catenin complex.
Activated H-Ras Blocks the Interaction of b-Catenin 
with APC and Decreases b-Catenin–P-Ser Content
The above results prompted us to examine the interaction
of b-catenin with other known partners in Neo versus Ras
cells. Because of the relevance of the b-catenin–APC in-
teraction in the regulation of cytoplasmic b-catenin levels,
we investigated whether activated H-Ras could influence
such interaction. High levels of soluble b-catenin coprecip-
itated with APC in control Neo cells (Fig. 5 a, IP: APC,
lane Neo), whereas very low levels of b-catenin were de-
tected in the APC immunocomplexes of PamV12Ras cells
(Fig. 5 a, IP: APC, Ras lane), even though the level of
APC was similar in both cell types (Fig. 5 a, lysates). On
the other hand, similar levels of GSK3b protein were de-
Figure 5. Stable expression of V12Ras in Pam212 keratinocytes inhibits b-catenin–APC interaction, but does not induce stable interac-
tion of b-catenin with GSK3b or affect GSK3b activity. (a) Soluble extracts from PamNeo (Neo) and PamV12Ras (Ras) cells were im-
munoprecipitated with anti-APC antibodies and subjected to immunoblotting for b-catenin (bottom, IP: APC). As a control of the APC
level, the extracts were immunoblotted with anti-APC antibodies (top, lysates). (b) Soluble extracts from PamNeo (Neo) and
PamV12Ras (Ras) cells were immunoprecipitated with anti–b-catenin (mouse mAb) (middle, IP: b-catenin) or anti-GSK3b (bottom,
IP: GSK3b) and subjected to immunoblotting for b-catenin, GSK3b, and P-Ser9GSK3b, as indicated. As a control, total cell extracts
from Neo and Ras cells (top, lysates) were also included in the immunoblottings. (c) GSK3b activity was assayed in crude cell extracts
of control PamNeo (Neo) and PamV12Ras cells from three independent infections (Ras1, Ras2, and Ras3) in the presence and absence
of 50 mM lithium chloride using the specific peptide GSM as substrate. The specific activity is represented as the percentage of the dif-
ference between the values obtained in the absence and presence of lithium chloride in each cell line. Samples were analyzed in dupli-
cate, and the results show the average value and SD. (d) Lef-1/Tcf–dependent transcriptional activity was measured in control PamNeo
(Neo) and PamV12Ras (Ras) cells using pTOPFLASH (Top) and pFOPFLASH (Fop) reporter vectors containing multimerized wild-
type (Top) or mutated (Fop) Lef-1/Tcf binding sites. Assays were performed in duplicate samples, and the results show the average
value and SD.Espada et al. H-Ras Stabilization of b-Catenin 975
tected in whole cell extracts from control Neo and Ras
cells (Fig. 5 b, lysates), but no stable association of b-cate-
nin with GSK3b was found in either cell line (Fig. 5 b, IP
b-catenin or GSK3b).
To investigate whether the disturbed interaction of
b-catenin with APC induced by activated H-Ras was due
to inhibition of GSK3b, we analyzed its activity in crude
cell extracts from control PamNeo and PamV12Ras cells.
Ras-transformed cells from three independent infection
assays (Ras1, 2, and 3) showed a level of GSK3b activity
sensitive to lithium chloride similar or slightly higher to
that of control cells (Fig. 5 c). In addition, endogenous
phosphorylation of GSK3b at Ser9 in Ras-expressing cells
was slightly higher than in control Neo cells (Fig. 5 b).
These results indicate that the overall activity of GSK3b in
Pam212 cells was not significantly decreased by overex-
pression of activated H-Ras. Nevertheless, a slight in-
crease of about twofold in basal Lef-1/Tcf–dependent
transcriptional activity was observed in Ras-transformed
cells (Fig. 5 d), suggesting a weak activation of b-catenin
signaling in these cells.
To further analyze the status of b-catenin in control
and Ras-transformed keratinocytes, we performed in vivo
phosphorylation analysis on both cell types after 4 h of
metabolic labeling. The level of b-catenin phosphorylation
in PamV12Ras cells resulting from two independent infec-
tions, Ras1 and Ras2, was significantly lower than that of
parental Pam212 cells (Fig. 6 a). Quantitive analysis of the
phosphorylated and total immunoprecipitated b-catenin
indicated that the ratio of [32P]b-catenin in Ras1 and Ras2
keratinocytes was 6% and 17% relative to that of the pa-
rental cells. In addition, the phosphoamino acid analysis of
immunoprecipitated b-catenin showed that P-Ser was the
major phosphorylated amino acid, and, as expected, the
relative P-Ser content of b-catenin in Ras-transduced cells
was much lower than that of parental cells (Fig. 6 b). The
P-Tyr content of b-catenin could not be detected in the
phosphoamino acid analysis, probably because of the lower
stability of P-Tyr residues to acid hydrolysis (Duclos et al.,
1991) or to a low level of P-Tyr labeling in the 4-h pulse, in
contrast to the steady state levels detected in the immuno-
precipitation analysis (Fig. 3 c). These results indicate that
activated H-Ras induces cytoplasmic accumulation of hy-
pophosphorylated  b-catenin and inhibits its interaction
Figure 6. In vivo phosphorylation of b-catenin is
strongly decreased in V12Ras-overexpressing ke-
ratinocytes and mainly affects the P-Ser content.
(a)  b-catenin was immunoprecipitated from
32P-metabolically labeled Pam212 (P) and
PamV12Ras cells from two independent infec-
tion assays (Ras1 and Ras2), resolved on poly-
acrylamide gel and subjected to autoradiography
(top) and immunoblotting of the same gel for
b-catenin (bottom). The 32P-ratio of b-catenin in
the different cell lines was quantitated by densi-
tometric scanning of the bands present in the au-
toradiogram and immunoblotting. (b) Phospho-
amino acid analysis of b-catenin.  32P–b-catenin
bands from Pam and Ras2 (Ras) cells were ex-
cised from the membranes and processed as de-
scribed in Materials and Methods (top). Migra-
tion of standard amino acids, identified by
ninhydrin staining, is indicated at the bottom and
by the ovals (top). The TLC plates were simulta-
neously autoradiographed for 21 d. Only 32P-Ser
could be detected, and it was strongly reduced in
Ras cells.The Journal of Cell Biology, Volume 146, 1999 976
Figure 7. Expression of constitutively active PI3K inhibits
b-catenin–APC interaction and induces cytoplasmic and nu-
clear accumulation of b-catenin. (a) Soluble extracts from
control PamPuromycin (Puro)- and p110CAAX-overexpress-
ing cells from two independent infections (p110S1 and
p110S2) were immunoprecipitated with anti-APC antibodies
and subjected to immunoblotting for b-catenin (bottom, IP:
APC). As control of the APC and b-catenin levels, the ex-
tracts were also immunoblotted with anti-APC (top, lysates)
and anti–b-catenin (middle, lysates) antibodies. (b) Stable
overexpression of V12Ras and p110CAAX induces cytoplas-
mic and nuclear accumulation of microinjected GST–b-cate-
nin. Confluent patches of PamV12Ras (Ras), Pamp110CAAX
(p110) and Pam212 (Pam) cells were microinjected with GST–
b-catenin protein (1 mg/ml) and after 4 h fixed in cold metha-
nol. Cells were stained for b-catenin (mouse mAb) and E-cad-
herin, as indicated. Microinjected cells were identified by
coinjection of dextran–Texas red. Note the cytoplasmic and
nuclear staining of b-catenin in Ras and p110 microinjected
cells, whereas the staining of E-cadherin remained at the cell–
cell contacts. Images were obtained in an Axiophot micro-
scope. Bars, 10 mm.Espada et al. H-Ras Stabilization of b-Catenin 977
with APC in keratinocytes, through a mechanism appar-
ently independent of stable interactions with or reduced
activity of GSK3b.
Overexpression of Constitutively Active PI3K Is 
Sufficient to Stabilize Cytoplasmic b-Catenin
To get additional information on the involvement of PI3K
in the stabilization of cytoplasmic b-catenin, Pam212 cells
overexpressing the membrane-bound form of p110a sub-
unit of PI3K (p110CAAX) and puromycin-resistant con-
trol cells were generated by retroviral transduction. Pam-
p110 cells from two independent infections (p110S1 and
p110S2) behaved similarly to PamV12Ras cells with re-
spect to b-catenin and APC content. Thus, no changes in
the total level of both proteins (Fig. 7 a, lysates) and a
strong reduction in the level of b-catenin–APC interaction
(Fig. 7 a, bottom, IP: APC) were observed in p110 cells,
when compared with control puromycin-resistant (Puro)
cells.
The effect of p110a expression on b-catenin localization
was further investigated by microinjection of recombinant
GST–b-catenin fusion protein. 4 h after microinjection, a
strong cytoplasmic and nuclear accumulation of b-catenin
was observed in PamV12Ras (Ras) and Pamp110a (p110)
cells (Fig. 7 b). In both cell types, b-catenin staining was
also detected at the cell–cell contacts of the microinjected
cells. In contrast, b-catenin staining was exclusively de-
tected at the cell–cell contacts after microinjection of the
GST–b-catenin fusion protein in the parental Pam212
(Pam) cells (Fig. 7 b), possibly because of its quick deg-
radation or incorporation into junctions. In Ras and
p110 microinjected cells staining with anti–GST antibod-
ies showed localization of the exogenous protein at the
membrane, cytoplasm, and nucleus but only at the mem-
brane junctions in Pam cells (data not shown). On the
other hand, staining of E-cadherin at the cell–cell contacts
was not modified in p110 cells (Fig. 7 b), indicating that
PI3K activity alone is not sufficient to disrupt cell–cell ad-
hesion in mouse keratinocytes.
The stabilization of endogenous b-catenin in cells over-
expressing either V12Ras or p110-CAAX was confirmed
by pulse–chase experiments. As can be observed in Fig. 8
a, b-catenin was quickly degraded in both control puromy-
cin (Puro)- and neomycin (Neo)-transduced cells. In con-
trast, the metabolic stability of endogenous b-catenin was
significantly increased in V12Ras (Ras)- and p110CAAX
(p110)-overexpressing cells (Fig. 8 a). Quantification of
Figure 8. Increased metabolic sta-
bility of b-catenin in Ras- and
p110CAAX-overexpressing kera-
tinocytes. (a) Control (Neo and
Puro), PamV12Ras (Ras), and
Pamp110CAAX (p110) cells were
pulse-labeled for 1 h with [35S]me-
thionine/cysteine and chased at the
indicated times. Labeled b-catenin
was detected by immunoprecipita-
tion and processed as described in
Materials and Methods. (b) The in-
tegrated density of the b-catenin–
labeled bands at each chase time
was normalized to that obtained at
chase time 0 in each cell line. As-
says were performed in two inde-
pendent experiments for each cell
type, and the results show the aver-
age value and SD. See the increased
stability of b-catenin in Ras- and
p110-overexpressing cells as com-
pared with control Neo and Puro
cells.The Journal of Cell Biology, Volume 146, 1999 978
the autoradiograms shown in Fig. 8 a indicated a half-life
for b-catenin of z1 h in control Pam cells, and of .4 h in
V12Ras- and p110CAAX-overexpressing cells (Fig. 8 b).
These results demonstrate that the stability of cytoplasmic
b-catenin is increased by the expression of V12Ras and
constitutively active PI3K in Pam212 keratinocytes.
Discussion
Alterations in the expression or function of the E-cad-
herin/catenin adhesion system occur frequently in a wide
variety of human carcinomas (for review see Takeichi,
1993; Birchmeier and Behrens, 1994). Indeed, a causal role
for the loss of E-cadherin has been recently demonstrated
during the transition from adenoma to invasive carcinoma
(Perl et al., 1998). The molecular mechanisms underlying
the loss of expression or functionality of individual compo-
nents of the cadherin/catenin complexes in tumorigenesis
are still poorly understood. The implication of b-catenin in
the Wnt signaling pathway has opened new avenues in the
study of the modulation of the cadherin–adhesion com-
plexes during tumor progression (Peifer, 1997; Pennisi,
1998). However, it is still largely unknown if other signal-
ing pathways frequently activated in tumor cells and, more
specifically, H-Ras activation can influence the signaling
activity of b-catenin. Our results indicate that activation of
H-Ras induces the dismantling of E-cadherin/catenin com-
plexes and the stabilization of hypophosphorylated cyto-
plasmic b-catenin through signaling pathway(s) involving
PI3K that lead to the inhibition of b-catenin–APC interac-
tion and to a stable interaction of b-catenin with PI3K
complex. In addition, activation of PI3K is sufficient to
promote the stabilization of cytoplasmic b-catenin and its
nuclear translocation.
H-Ras expression in mouse epidermal keratinocytes in-
duced a decrease in the total levels of E-cadherin and
a-catenin without significantly affecting the levels of
b-catenin, as previously described in intestinal and mam-
mary cells (Novak et al., 1998). In addition, in V12Ras-
expressing keratinocytes, most of the E-cadherin and asso-
ciated b-catenin are found in the detergent soluble frac-
tion, indicating a weak interaction of the E-cadherin/
catenin complexes with the cytoskeleton in those cells. We
suggest that activation of H-Ras can affect the E-cadherin/
catenin complexes in epidermal keratinocytes via signaling
mechanisms different from those leading to increased
P-Tyr, in contrast to previous reports using other cell types
(Kinch et al., 1995). Despite the biochemical effects on
cadherin complexes induced by activated H-Ras in mouse
keratinocytes, no significant differences could be observed
in the morphological phenotype of the parental Pam212,
control PamNeo, and PamV12Ras cells when growing at
medium high density. These results differ from those pre-
viously reported after Ras transformation of MDCK cells
(Behrens et al., 1989; Vleminckx et al., 1991) or mammary
MCF10A cells (Kinch et al., 1995; Zhong et al., 1997),
where a more epitheloid or fibroblastic phenotype was
sometimes observed. These differences may be related to
the level of activated H-Ras expression obtained in the
different studies or may be specific of the cell system ana-
lyzed. In this sense, it is worth mentioning that tyrosine
phosphorylation of catenins plays a positive role in the
stratification process in differentiated keratinocytes (Ca-
lautti et al., 1998). In spite of those differences, our results
indicate that even in situations where a full phenotypic
transformation is not observed, activated H-Ras is able to
significantly modify the E-cadherin/catenin complexes as
in the murine Pam212 epidermal keratinocytes. Thus, the
modification of the adhesion complexes might be an early
event driven by H-Ras transformation.
Our microinjection studies are in agreement with those
showing that V12Ras leads to the loss of E-cadherin and
b-catenin from cell–cell contacts in MDCK cells, depen-
dent on both PI3K and MAPK activities (Potempa and
Ridley, 1998). However, no cytoplasmic localization of
b-catenin was observed and the a-catenin status was not
analyzed in this study. These differences can be due to dif-
ferent fixation and permeabilization procedures or to the
cell systems analyzed.
In addition to the involvement of PI3K in the Ras-
dependent destabilization of cadherin complexes and relo-
calization of b-catenin, our results provide evidence for a
strong association of cytoplasmic b-catenin with PI3K
both in vivo and in vitro. In vitro binding studies clearly
show a direct interaction between b-catenin and p85a,
(Fig. 4 c), suggesting that the in vivo interactions might be
mediated by the regulatory subunit of PI3K. In fact, p85a
is able to interact with endogenous b-catenin in control
Pam212 cells, and this interaction is significantly increased
in V12Ras-overexpressing cells. Interestingly, concomi-
tant with the increased association with the regulatory
subunit, association of the catalytic subunit of PI3K with
b-catenin is strongly induced in PamV12Ras (Fig. 4 a).
These observations suggest that the PI3K heterodimer is
involved in the stabilization of cytoplasmic b-catenin in-
duced by activated H-Ras in keratinocytes.
The involvement of PI3K in the Ras-induced b-catenin
stabilization is further supported by analysis of Pam212
keratinocytes overexpressing the membrane-bound cata-
lytic subunit of PI3K (Pamp110 cells). In these cells as well
as in PamV12Ras cells, microinjected recombinant b-cate-
nin is stabilized in the cytoplasm and translocated to the
nucleus after 4 h of microinjection. In contrast, the exoge-
nous catenin is apparently degraded or incorporated into
junctions in control cells (Fig. 7 b). Furthermore, the
pulse–chase analysis demonstrates that expression of V12-
Ras or p110CAAX significantly reduced the turnover of
endogenous b-catenin. These results indicate that consti-
tutive activation of PI3K is sufficient for stabilization of
b-catenin and its translocation to the nucleus, although
not for disruption of cell–cell junctions. One interesting
possibility is that other pathways activated by V12Ras, like
MAPK, are required for initial dismantling of adhesion
complexes, and that cytoplasmic b-catenin is then stabi-
lized because of its interaction with activated PI3K. This is
now being investigated in further detail.
Here, we provide evidence to support that H-Ras-
induced stabilization of b-catenin occurs through interfer-
ence with its APC interaction and decrease in the levels of
serine phosphorylation. The ability of b-catenin to associ-
ate with APC is significantly reduced in keratinocytes sta-
bly expressing V12Ras. However, in contrast to previous
reports, our present results indicate that the stabilization
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activated H-Ras might occur by mechanism(s) indepen-
dent of stable interaction with GSK3b or significant alter-
ations in the total GSK3b activity (Delcommenne et al.,
1998). Inhibition of additional kinase(s) or activation of
phosphatase(s) may be involved in the dephosphorylation
of b-catenin upon Ras activation. In this sense, it has been
reported that b-catenin can also be phosphorylated by di-
acylglycerol-independent protein kinase C isoforms (Or-
ford et al., 1997), and that its stability is modulated by
PP2A phosphatase (Seeling et al., 1999). In Ras-express-
ing mouse keratinocytes b-catenin might transiently inter-
act with distinct cytoplasmic partners for its translocation
to the nucleus. Interestingly, in our Ras-expressing kerati-
nocytes only a slight increment in Lef-1/Tcf–dependent
transcriptional activity is observed, suggesting that addi-
tional factors are needed to fully induce b-catenin tran-
scriptional activation (see Prieve and Waterman, 1999).
Regarding the mechanism(s) leading to b-catenin stabi-
lization, it is not known whether interaction with PI3K can
modulate its association to APC or directly contribute to
its stabilization in the cytoplasm. Interestingly, b-catenin–
APC interaction is also blocked in p110CAAX-overex-
pressing keratinocytes (Fig. 7 a), but similar levels of total
GSK3b activity have been observed in controls, PI3K and
V12Ras transformants (Espada, J., and A. Cano, unpub-
lished results). We speculate that p85a (and/or p110a)
might compete with other b-catenin partners, such as APC
or E-cadherin, rendering the molecule inaccessible for the
ubiquitin-proteasome degradation. On the other hand,
PI3K activation by H-Ras can further increase the b-cate-
nin–PI3K interaction. The possibility of a recruitment of
b-catenin into vesicles through PI3K interaction cannot be
discarded, although it is not supported from the immuno-
fluorescent staining (Figs. 1 and 7 b). 
In summary, our results show a direct effect of H-Ras
activation on the stabilization of b-catenin cytoplasmic
pools in epidermal keratinocytes. This effect is mediated
by the PI3K effector and involves a novel b-catenin–PI3K
complex and the inhibition of b-catenin–APC interaction.
Together with recent data from other groups (Delcom-
menne et al., 1998; Potempa and Ridley, 1998; Sander et
al., 1998), our results highlight the role of PI3K as a main
regulator of different signaling pathways impinging on the
modulation of the E-cadherin–mediated adhesion and
b-catenin signaling. They also indicate that H-Ras activa-
tion can induce b-catenin signaling and, thus, can contrib-
ute to the present knowledge on the molecular mecha-
nisms of cancer development.
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